Targeting circ-CYP24A1 in exosomes significantly reduced tumorigenic behaviors, underscoring its potential as a non-invasive biomarker for cSCC diagnosis and a novel therapeutic target for limiting tumor progression 167. The gene discussed is CYP24A1; the disease is neoplasm.